ACADIA Pharmaceuticals Inc.
ACAD
$29.67
$0.280.94%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 766.10% | -98.67% | 281.13% | 169.18% | 40.44% |
| Total Depreciation and Amortization | 5.48% | 2.36% | -0.88% | 0.51% | -0.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.42% | 105.96% | -2,064.85% | -5.67% | 38.21% |
| Change in Net Operating Assets | 198.95% | 115.02% | -602.20% | -158.09% | 298.10% |
| Cash from Operations | 196.58% | 169.73% | -165.60% | 16.15% | 214.70% |
| Capital Expenditure | 2.36% | -30.14% | -932.22% | -30.64% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.81% | 237.85% | 34.32% | -83.65% | 65.34% |
| Cash from Investing | -112.87% | 218.64% | 29.59% | -83.29% | 65.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 148.03% | -81.33% | 140.54% | -40.94% | 768.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 148.03% | -81.33% | 140.54% | -40.94% | 768.12% |
| Foreign Exchange rate Adjustments | 8.00% | 257.14% | -- | -100.00% | 580.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.67% | 227.57% | -1,979.49% | -88.10% | 135.96% |